Literature DB >> 11472404

The GOR gene product cannot cross-react with hepatitis C virus in humans.

R Koike1, T Iizuka, T Watanabe, N Miyasaka.   

Abstract

GOR (GOR47--1) is an epitope thought to be a host-derived antigen cross-reactive with hepatitis C virus (HCV) since it was isolated from a cDNA library of host animals reactive with sera of HCV-positive patients. An enzyme immunosorbent assay (ELISA) using this epitope as antigen is of sufficient sensitivity and specificity for screening patients with HCV. However, the relationship between GOR47--1 epitope and autoimmune phenomena associated with HCV infection or autoimmune hepatitis is controversial. Here we isolated the human GOR gene and found that the GOR47--1 epitope was not translated in humans due to a single base replacement from chimpanzee. Furthermore, we found some patients who had antibodies against another epitope, which is translated (GOR1--125) in humans, although there was no correlation between the existence of anti-GOR47--1 or anti-GOR1--125 Ab and autoimmune phenomena. Serum IgG levels did not influence the titres of these antibodies. Taken together with the results of several other studies, our finding that the GOR47--1 epitope cannot be translated into a protein suggests that there is little relationship between autoimmunity and the GOR gene product in human beings. We also discuss here the possible mechanism of cross-reactivity between HCV and the GOR gene product.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472404      PMCID: PMC1906082          DOI: 10.1046/j.1365-2249.2001.01508.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Hepatitis C virus and Sjögren's syndrome.

Authors:  P Almasio; G Provenzano; M Scimemi; G Cascio; A Craxì; L Pagliaro
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

2.  Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia.

Authors:  C Ferri; F Greco; G Longombardo; P Palla; A Moretti; E Marzo; P V Fosella; G Pasero; S Bombardieri
Journal:  Arthritis Rheum       Date:  1991-12

3.  Measurement of anti-GOR antibodies in prevention of post-transfusion non-A, non-B hepatitis.

Authors:  H Yoshizawa; N Nojiri; K Takahashi
Journal:  Lancet       Date:  1991-01-05       Impact factor: 79.321

4.  An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen.

Authors:  S Mishiro; K Takeda; Y Hoshi; A Yoshikawa; T Gotanda; Y Itoh
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

5.  Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

Authors:  P Cacoub; C Renou; E Rosenthal; P Cohen; I Loury; V Loustaud-Ratti; A M Yamamoto; A C Camproux; P Hausfater; L Musset; P Veyssier; G Raguin; J C Piette
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

6.  Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process.

Authors:  S Mishiro; Y Hoshi; K Takeda; A Yoshikawa; T Gotanda; K Takahashi; Y Akahane; H Yoshizawa; H Okamoto; F Tsuda
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321

7.  Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.

Authors:  S Fargion; A Piperno; M D Cappellini; M Sampietro; A L Fracanzani; R Romano; R Caldarelli; R Marcelli; L Vecchi; G Fiorelli
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

8.  The GOR47-1 sequence in human DNA encoding for a potential autoantigen in connection with hepatitis C--a sequence not only reserved for humans.

Authors:  R H Dennin; Z Chen; J Wo
Journal:  Z Gastroenterol       Date:  1998-10       Impact factor: 2.000

9.  Virus-induced autoimmunity in hepatitis C virus infections: a rare event.

Authors:  B M McFarlane; C Bridger; C J Tibbs; M G Saleh; A Fuzio; G Verucchi; L Attard; A Boschi; F Chiodo; I G McFarlane
Journal:  J Med Virol       Date:  1994-01       Impact factor: 2.327

10.  Anti-GOR and hepatitis C virus in autoimmune liver diseases.

Authors:  G Michel; A Ritter; G Gerken; K H Meyer zum Büschenfelde; R Decker; M P Manns
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321

View more
  3 in total

1.  Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies.

Authors:  Juan A Quiroga; Inmaculada Castillo; Javier Bartolomé; Vicente Carreño
Journal:  Clin Vaccine Immunol       Date:  2007-08-15

2.  Hepatitis C virus, human immunodeficiency virus and Pseudomonas phage PS5 triad share epitopes of immunogenic determinants.

Authors:  Zhabiz Golkar; Nusrat Jamil
Journal:  Virol J       Date:  2010-11-26       Impact factor: 4.099

3.  Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome?

Authors:  Maria Rosaria D'Apice; Antonio Novelli; Alessandra di Masi; Michela Biancolella; Antonio Antoccia; Francesca Gullotta; Norma Licata; Daniela Minella; Barbara Testa; Anna Maria Nardone; Giampiero Palmieri; Emma Calabrese; Livia Biancone; Caterina Tanzarella; Marina Frontali; Federica Sangiuolo; Giuseppe Novelli; Francesco Pallone
Journal:  BMC Med Genet       Date:  2015-04-02       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.